title: Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study".
authors.affiliation: European Georges Pompidou Hospital and Paris Descartes University, Paris, France.
authors.forename: Eloi
authors.initials: E
authors.lastname: Marijon
authors.affiliation: European Georges Pompidou Hospital and Paris Descartes University, Paris, France.
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Le Heuzey
authors.affiliation: Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
authors.forename: Stuart
authors.initials: S
authors.lastname: Connolly
authors.affiliation: Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
authors.forename: Sean
authors.initials: S
authors.lastname: Yang
authors.affiliation: Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
authors.forename: Janice
authors.initials: J
authors.lastname: Pogue
authors.affiliation: Boehringer Ingelheim Pharma GmbH & Co KG, Clinical Development and Medical Affairs, Ingelheim am Rhein, Germany, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany.
authors.forename: Martina
authors.initials: M
authors.lastname: Brueckmann
authors.affiliation: Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
authors.forename: John
authors.initials: J
authors.lastname: Eikelboom
authors.affiliation: Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
authors.forename: Ellison
authors.initials: E
authors.lastname: Themeles
authors.affiliation: Cardiovascular Research Foundation and Thomas Jefferson Medical College, New York, NY.
authors.forename: Michael
authors.initials: M
authors.lastname: Ezekowitz
authors.affiliation: Uppsala Clinical Research Centre, University Hospital, Uppsala, Sweden.
authors.forename: Lars
authors.initials: L
authors.lastname: Wallentin
authors.affiliation: Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
authors.forename: Salim
authors.initials: S
authors.lastname: Yusuf
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D000991:Antithrombins / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000401:mortality*; D001562:Benzimidazoles / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D014859:Warfarin / Q000008:administration & dosage*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin